1
|
Wotton L, Gali B, Carvalho K, Tarling T, Matzke L, Watson PH. Analysis of Trends in Biospecimen Complexity in Cancer Research Over Two Decades. Biopreserv Biobank 2021; 20:195-200. [PMID: 34515517 DOI: 10.1089/bio.2021.0078] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Background: Over time, researchers' demand for increased quality and quantity of biospecimens has risen. However, quality is multifaceted, ranging from simple to complex, and comes at a cost. Therefore, to be sustainable and ensure optimal utilization of their resources (supply), biobanks must consider the trends in biospecimen use to predict the needs for future biospecimen quality (demand). Methods: An unbiased selection process was used to identify research articles from across the spectrum of cancer research from the PubMed database. A set of 225 articles utilizing human biospecimens were randomly selected for review (75 articles from each of three time intervals; 2000, 2010, 2020). Criteria for determining the source and complexity of quality of biospecimens were developed and overall concordance between two independent observers abstracting the data was then confirmed (k = 0.87) to validate the criteria. Results: We observed increased use of dual biospecimen formats (20%-36% of articles, p = 0.03), matched samples (16%-37% of articles, p = 0.0033), and biospecimens with associated outcomes data (20%-49%, p = 0.0002). In addition, the use of two or more cohorts increased over time (p = 0.03). The mechanism through which biospecimens were obtained also changed over time with an increase in the diversity of collection pathways used (p = 0.006). Conclusions: The complexity of biospecimens being used in cancer research and the diversity of collection pathways through which these are obtained has changed significantly. This observation is important for biobanks given that the cost to support the supply of biospecimens with complex extrinsic as opposed to simple intrinsic quality characteristics is greater. For biobanks to manage sustainability, optimize utilization, and meet changing research demand, they may need to adjust their operational models to better support the supply of these types of biospecimens.
Collapse
Affiliation(s)
- Lauren Wotton
- Island Medical Program, University of British Columbia, Victoria, Canada
| | - Brent Gali
- Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer, Victoria, Canada
| | - Karlene Carvalho
- Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer, Victoria, Canada
| | - Tamsin Tarling
- Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer, Victoria, Canada
| | - Lise Matzke
- Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer, Victoria, Canada
| | - Peter H Watson
- Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer, Victoria, Canada.,Canadian Tissue Repository Network, Vancouver, Canada
| |
Collapse
|
2
|
Vercauteren S, Tarling T, Matzke L, Stoll D, Tarling T. Participating in Pediatric Biobanking as a Researcher, Parent, and Advocate: Would I Say Yes? Biopreserv Biobank 2020; 19:98-100. [PMID: 33372833 DOI: 10.1089/bio.2020.0115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Suzanne Vercauteren
- Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, BC, Canada.,Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.,Department of Pathology and Laboratory Medicine, BC Children's Hospital BioBank, Vancouver, BC, Canada.,OBER, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Tamsin Tarling
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.,Department of Pathology and Laboratory Medicine, BC Children's Hospital BioBank, Vancouver, BC, Canada.,OBER, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Lise Matzke
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.,OBER, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Dominik Stoll
- Provincial Health Services Authority (PHSA), BC, Canada
| | - Tamsin Tarling
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.,Department of Pathology and Laboratory Medicine, BC Children's Hospital BioBank, Vancouver, BC, Canada.,OBER, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
3
|
Affiliation(s)
- Lise Matzke
- Biobanking and Biospecimen Research Services, Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, Canada
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada
| | - Sheila O'Donoghue
- Biobanking and Biospecimen Research Services, Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, Canada
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada
| | - Peter H Watson
- Biobanking and Biospecimen Research Services, Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, Canada
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada
| |
Collapse
|
4
|
Matzke L, O'Donoghue S, Watson PH. Access ISBER Best Practice Education Online and Keep Your Practices Current. Biopreserv Biobank 2019; 17:625-626. [PMID: 31742426 DOI: 10.1089/bio.2019.29061.ljm] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Affiliation(s)
- Lise Matzke
- Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center, Victoria, Canada.,Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada
| | - Sheila O'Donoghue
- Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center, Victoria, Canada.,Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada.,Canadian Tissue Repository Network, Vancouver, Canada
| | - Peter H Watson
- Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center, Victoria, Canada.,Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada.,Canadian Tissue Repository Network, Vancouver, Canada
| |
Collapse
|
5
|
Affiliation(s)
- Victoria Hartman
- Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center and University of British Columbia, Victoria, Canada
| | - Lise Matzke
- Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center and University of British Columbia, Victoria, Canada
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada
| | - Peter H. Watson
- Biobanking and Biospecimen Research Services, Deeley Research Centre, British Columbia Cancer-Victoria Center and University of British Columbia, Victoria, Canada
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, Canada
| |
Collapse
|
6
|
Rush A, Matzke L, Cooper S, Gedye C, Byrne JA, Watson PH. Research Perspective on Utilizing and Valuing Tumor Biobanks. Biopreserv Biobank 2019; 17:219-229. [DOI: 10.1089/bio.2018.0099] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Affiliation(s)
- Amanda Rush
- Children's Cancer Research Unit, Kids Research, The Children's Hospital at Westmead, Discipline of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
| | - Lise Matzke
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
| | - Simon Cooper
- NSW Health Statewide Biobank, NSW Health Pathology, The Professor Marie Bashir Centre, Sydney, Australia
| | - Craig Gedye
- NSW Health Statewide Biobank, NSW Health Pathology, The Professor Marie Bashir Centre, Sydney, Australia
| | - Jennifer A. Byrne
- Children's Cancer Research Unit, Kids Research, The Children's Hospital at Westmead, Discipline of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
| | - Peter H. Watson
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
- Biobanking and Biospecimen Research Services, BC Cancer Research Center, Vancouver, Canada
- Canadian Tissue Repository Network, Deeley Research Centre, British Columbia Cancer-Victoria Center and University of British Columbia, Victoria, Canada
| |
Collapse
|
7
|
O'Donoghue S, Matzke L, Watson P. ISBER Best Practice-Based Education: ISBER-Canadian Tissue Repository Network Introduction to Biobanking. Biopreserv Biobank 2018; 16:13-15. [DOI: 10.1089/bio.2017.0116] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Sheila O'Donoghue
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, British Columbia, Canada
| | - Lise Matzke
- Department of Pathology and Laboratory Medicine, Office of Biobank Education and Research, University of British Columbia, Vancouver, British Columbia, Canada
| | - Peter Watson
- DRC, BC Cancer Agency, Vancouver, British Columbia, Canada
| |
Collapse
|
8
|
Hartman V, Castillo-Pelayo T, Babinszky S, Dee S, Leblanc J, Matzke L, O'Donoghue S, Carpenter J, Carter C, Rush A, Byrne J, Barnes R, Mes-Messons AM, Watson P. Is Your Biobank Up to Standards? A Review of the National Canadian Tissue Repository Network Required Operational Practice Standards and the Controlled Documents of a Certified Biobank. Biopreserv Biobank 2018; 16:36-41. [DOI: 10.1089/bio.2017.0065] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Affiliation(s)
- Victoria Hartman
- Tumour Tissue Repository, BC Cancer Agency, Victoria, BC, Canada
| | | | - Sindy Babinszky
- Tumour Tissue Repository, BC Cancer Agency, Victoria, BC, Canada
| | - Simon Dee
- Tumour Tissue Repository, BC Cancer Agency, Victoria, BC, Canada
| | - Jodi Leblanc
- Tumour Tissue Repository, BC Cancer Agency, Victoria, BC, Canada
| | - Lise Matzke
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
| | | | - Jane Carpenter
- NSW Health Pathology Biobanking Services, Chatswood, NSW, Australia
| | - Candace Carter
- University of Sydney NHMRC Clinical Trials Centre, Camperdown, NSW, Australia
| | - Amanda Rush
- Children's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, NSW, Australia
| | - Jennifer Byrne
- Children's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, NSW, Australia
- University of Sydney Discipline of Child and Adolescent Health, The Children's Hospital at Westmead, NSW, Australia
| | - Rebecca Barnes
- Canadian Tissue Repository Network, BC Cancer Agency, Victoria, BC, Canada
| | | | - Peter Watson
- Tumour Tissue Repository, BC Cancer Agency, Victoria, BC, Canada
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
- Canadian Tissue Repository Network, BC Cancer Agency, Victoria, BC, Canada
| |
Collapse
|
9
|
Meredith AJ, Slotty A, Matzke L, Babinszky S, Watson PH. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research. Biopreserv Biobank 2015; 13:356-62. [DOI: 10.1089/bio.2014.0081] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Affiliation(s)
- Anna J. Meredith
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, BC Cancer Agency and UBC, Vancouver, British Columbia, Canada
| | - Alex Slotty
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, BC Cancer Agency and UBC, Vancouver, British Columbia, Canada
| | - Lise Matzke
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, BC Cancer Agency and UBC, Vancouver, British Columbia, Canada
| | - Sindy Babinszky
- Tumour Tissue Repository, Trev and Joyce Deeley Research Centre, BC Cancer Agency, Victoria, British Columbia, Canada
| | - Peter H. Watson
- Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, BC Cancer Agency and UBC, Vancouver, British Columbia, Canada
- Tumour Tissue Repository, Trev and Joyce Deeley Research Centre, BC Cancer Agency, Victoria, British Columbia, Canada
| |
Collapse
|
10
|
Matzke L, Dee S, Bartlett J, Damaraju S, Graham K, Johnston R, Mes-Masson AM, Murphy L, Shepherd L, Schacter B, Watson PH. A practical tool for modeling biospecimen user fees. Biopreserv Biobank 2015; 12:234-9. [PMID: 25162459 DOI: 10.1089/bio.2014.0008] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The question of how best to attribute the unit costs of the annotated biospecimen product that is provided to a research user is a common issue for many biobanks. Some of the factors influencing user fees are capital and operating costs, internal and external demand and market competition, and moral standards that dictate that fees must have an ethical basis. It is therefore important to establish a transparent and accurate costing tool that can be utilized by biobanks and aid them in establishing biospecimen user fees. To address this issue, we built a biospecimen user fee calculator tool, accessible online at www.biobanking.org . The tool was built to allow input of: i) annual operating and capital costs; ii) costs categorized by the major core biobanking operations; iii) specimen products requested by a biobank user; and iv) services provided by the biobank beyond core operations (e.g., histology, tissue micro-array); as well as v) several user defined variables to allow the calculator to be adapted to different biobank operational designs. To establish default values for variables within the calculator, we first surveyed the members of the Canadian Tumour Repository Network (CTRNet) management committee. We then enrolled four different participants from CTRNet biobanks to test the hypothesis that the calculator tool could change approaches to user fees. Participants were first asked to estimate user fee pricing for three hypothetical user scenarios based on their biobanking experience (estimated pricing) and then to calculate fees for the same scenarios using the calculator tool (calculated pricing). Results demonstrated significant variation in estimated pricing that was reduced by calculated pricing, and that higher user fees are consistently derived when using the calculator. We conclude that adoption of this online calculator for user fee determination is an important first step towards harmonization and realistic user fees.
Collapse
Affiliation(s)
- Lise Matzke
- 1 University of British Columbia Office of Biobank Education and Research , Vancouver, British Columbia, Canada
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
Detailed documentation of the experimental materials and methods is essential for the validation of scientific papers. Human biospecimens are increasingly utilized as materials in cancer research and information about the biospecimens used is a component of this documentation. We hypothesized that previously reported biospecimen data are inadequate for accurate replication and/or validation of a substantial proportion of studies. To examine this issue, we analyzed biospecimen reporting in a representative cross section of publications over the past 12 years (1998, 2004, 2010) in the journals, Cancer Research (CR, n=46) and Clinical Cancer Research (CCR, n=73). We assessed biospecimen data in relation to the standards outlined as the Tier 1 recommended data elements from the Biospecimen Reporting for Improved Study Quality (BRISQ), in addition to ethics criteria. These data elements encompass features of biospecimens influenced by the patient, medical procedure, and biospecimen acquisition, handling and storage processes. Analysis found that while there was a significant increase in the reporting of ethics board approval status (p<0.008) and name of the ethics board (p<0.0001), there were no significant differences between these journals or over this period in reporting other biospecimen-related data elements. Of the 15 Tier 1 data elements assessed in CR and CCR, the data elements commonly obtained from the "Clinical Chart" (8/15 elements) were significantly better reported than elements that would typically be obtained from the "Biobank" (p<0.0001). Our findings demonstrate that reporting of biospecimen-related data elements has been incomplete. As one part of the solution to this issue, we propose the use of an online data-elements reporting tool (www.biobanking.ca) by biobanks. This BRISQ Report tool aims to help biobanks provide the relevant biospecimen-related data as a structured report, and to promote its inclusion as supplementary material in publications to improve the quality of future research studies.
Collapse
|
12
|
Affiliation(s)
- Jim Vaught
- Editor, Biopreservation & Biobanking, and President-elect, International Society for Biological and Environmental Repositories, Rockville, MD
| | - Akin Abayomi
- Chief Pathologist and Head, Division of Haematology, University of Stellenbosch, Cape Town, South Africa
| | - Tim Peakman
- Deputy CEO, UK Biobank, Adswood, Stockport, UK
| | - Peter Watson
- Professor, Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
- Professor, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Lise Matzke
- Project Manager, Office of Biobank Education and Research, Department of Pathology and Laboratory Medicine, University of British Columbia–Vancouver General Hospital, Vancouver, BC, Canada, and Deeley Research Centre, Victoria, BC, Canada
| | - Helen Moore
- Chief, Biorepositories and Biospecimen Research Branch, Cancer Diagnosis Program, US National Cancer Institute, Bethesda, MD
| |
Collapse
|
13
|
Leung C, Samra A, Matzke L, Allard M. Methodological Issues Related to Pathological Evaluation of Coronary Artery Stents. J Histotechnol 2013. [DOI: 10.1179/his.2009.32.4.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
14
|
Meredith A, Samra A, Matzke L, Leung C, McManus B. Gene and Protein Expression Alterations in the Myocardium following Mechanical Circulatory Assist in Heart Failure Patients. J Card Fail 2010. [DOI: 10.1016/j.cardfail.2010.06.184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|